P278 Feasibility study of adjuvant fluorouracil/epirubicin/cyclophosphamide (FEC 100) followed by triweekly docetaxel (D) plus trastuzumab (H) in HER2/neu positive early breast cancer

✍ Scribed by M. Tanaka; K. Anan; S. Umeda; M. Yamaguchi; H. Sasaki; Y. Rai; S. Ohno; U. Toh; K. Tamura; S. Mitsuyama

• Book ID: 114316617
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 55 KB
• Volume: 20
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(11)70220-x